The 2026 Hemp Ban: What Changes, Who's Affected, and What to Do About It

On November 12, 2026, the way federal law defines "hemp" changes, and with it the legal status of roughly 95% of the intoxicating hemp products currently sold in the United States.

This is the single most consequential piece of cannabis regulation since the 2018 Farm Bill legalized hemp in the first place. For consumers who've been buying delta-8 gummies at smoke shops, ordering hemp-derived THC beverages online, or picking up THCA flower at gas stations, the product category goes away at the federal level. For operators running state-licensed cannabis businesses, the ban changes nothing about their legal standing and probably shifts a significant slice of displaced consumer demand toward the dispensary channel. For the hemp industry itself, it's an extinction-level event estimated by the U.S. Hemp Roundtable to eliminate up to 95% of current SKUs.

This page is a living document. We update it whenever the legal situation moves. What follows is a comprehensive breakdown of what the law actually does, what's in active litigation, what it means state by state, what to do if you're a consumer or an operator, and answers to the questions people are actually searching.

What does Section 781 of H.R. 5371 actually change?

Section 781 of H.R. 5371 amends the Agricultural Marketing Act's definition of hemp in three ways. It replaces the delta-9-only test with a total-THC standard, caps finished-product THC at 0.4mg per container, and excludes synthetic and lab-converted cannabinoids from the hemp definition. The combined effect removes roughly 95% of intoxicating hemp products from federal legality starting November 12, 2026.

Congress passed H.R. 5371, the Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026 on November 12, 2025, and President Trump signed it the same day. Section 781 of Division B is where the hemp redefinition lives, and the three changes below are what carry the federal effect.

Change one: total THC replaces delta-9-only. The old definition (from the 2018 Farm Bill) classified cannabis as hemp if it contained less than 0.3% delta-9 THC by dry weight. Everything else (delta-8, delta-10, THCA, HHC, THCP) sat outside the definition, unregulated by concentration. This is the loophole the entire intoxicating hemp industry was built on. The new definition counts all psychoactive cannabinoids toward the 0.3% ceiling. A plant that was legal hemp on November 11, 2026 because its delta-9 content was 0.2% and its THCA content was unmeasured becomes non-hemp on November 12, 2026 because the THCA converts to THC when heated and the total THC reading exceeds 0.3%.

Change two: a 0.4 milligram per container cap for finished products. This is the rule that guts the consumable market. Any final hemp-derived product with more than 0.4mg of total THC per container is excluded from the definition of hemp and pushed back into Schedule I under the Controlled Substances Act. For reference, a standard dispensary gummy contains 5-10mg per piece, and a typical hemp-derived gummy on the market today contains 25-50mg per piece. The 0.4mg container cap covers the entire package, not per serving. A 20-count jar has 0.4mg total to distribute. That's roughly 1/12th of a single standard dose spread across 20 gummies.

Change three: synthetic and lab-converted cannabinoids are excluded. Products containing cannabinoids that are not capable of being naturally produced by Cannabis sativa L., or that are capable of being naturally produced but were synthesized or manufactured outside the plant, are explicitly carved out of the hemp definition. Delta-8 THC is almost entirely produced through acid-catalyzed isomerization of CBD. Under the new definition, that conversion process disqualifies the product regardless of concentration. HHC, THCP, and other lab-derived cannabinoids face the same exclusion.

The effective date is November 12, 2026. The FDA is required to publish lists of naturally occurring cannabinoids, THC-class cannabinoids, and all known cannabinoids with similar effects within 90 days of enactment. FDA was also directed to further define "container" for purposes of the 0.4mg cap.

What hemp products stay legal after November 12, 2026?

Industrial hemp for fiber, seed, and construction stays legal. So do CBD products under the 0.4mg total THC per container threshold, hemp seed as a food ingredient, and trace-THC topicals below the cap. State-licensed cannabis is unaffected since Section 781 amends the Agricultural Marketing Act. State cannabis programs are not in scope.

The U.S. Hemp Roundtable estimates that over 90% of currently marketed CBD products exceed the new 0.4mg per container threshold, even many that are marketed as non-intoxicating. Most CBD brands will need to reformulate to lower-THC isolate or full-spectrum-within-limits products to continue selling after November 12. Brands like Charlotte's Web, Cornbread Hemp, and the isolate lines from larger operators are positioned to survive because their product mix leans heavily toward isolate.

On the state-licensed side, a California, Michigan, Illinois, Massachusetts, New York, Colorado, or Nevada dispensary selling 10mg THC gummies in April 2026 is selling them through the same state-licensed channel on November 13, 2026. State programs operate under state law against a federal Schedule I backdrop that existed before November 12 and does not change after it. The only variables that shift are demand and price, both of which are discussed below.

The active litigation: why enforcement is already uneven

The federal law is set. The implementation is not. As of this writing (April 22, 2026), court orders in two states have temporarily blocked state-level hemp enforcement, and several more cases are pending.

Texas. The Texas Department of State Health Services (DSHS) Consumable Hemp Program issued rules on March 31, 2026, preemptively implementing a total-THC standard at the state level. The rules effectively banned THCA flower, smokable hemp, and most consumable hemp products across the state. Under the rules, retailer licensing fees would have jumped from $150 to $5,000 per location, and manufacturer fees to $10,000.

On April 7, 2026, the Texas Hemp Business Council (THBC), the Hemp Industry & Farmers of America (HIFA), and a group of state hemp manufacturers and retailers filed a 330-page complaint in Travis County District Court challenging the rules. Their argument: DSHS exceeded its regulatory authority by effectively rewriting the statutory definition of hemp, which only the Legislature has the constitutional power to do. On April 8, Travis County Judge Maya Guerra Gamble granted a temporary restraining order blocking enforcement of the smokable and consumable rules; the TRO took effect April 10. She declined to block the new licensing fees in the initial order. An evidentiary hearing on a longer-term temporary injunction is scheduled for April 23, 2026. If granted, the injunction would continue blocking enforcement until the case is fully resolved.

A separate Texas case, Sky Marketing Corp. v. DSHS (the Hometown Hero case), is pending before the Texas Supreme Court. It originated from a 2021 DSHS attempt to classify delta-8 THC as Schedule I through website notice instead of formal rulemaking. A Travis County district court issued an injunction in 2022, affirmed on appeal, and the case reached oral arguments at the Texas Supreme Court in January 2026. A ruling is pending. The core question is whether DSHS has authority to reclassify hemp-derived cannabinoids through administrative action, or whether that authority is reserved for the Legislature. A ruling for the hemp industry in Sky Marketing would strengthen the arguments in the current THBC case substantially.

Ohio. The state passed Senate Bill 56 in December 2025, enacting a state-level ban on intoxicating hemp products that took effect in March 2026. Two separate Ohio courts have since issued injunctions blocking enforcement for specific plaintiffs. On April 8, 2026, a Sandusky County judge blocked enforcement against hemp retailers in Fremont. On April 16, a Franklin County judge issued a TRO against enforcement for two Columbus-area plaintiffs, with a preliminary injunction hearing expected within two weeks.

A referendum campaign called Ohioans for Cannabis Choice is also collecting signatures to place a repeal of SB 56 on the November 2026 ballot. The campaign needs 250,000 signatures by mid-March 2026 to qualify. Whether that threshold was hit is unclear as of this writing.

Federal level. Two active legislative efforts could modify Section 781 before it takes effect. The Cannabinoid Safety and Regulation Act (S. 3474), introduced in December 2025 by Senators Wyden and Merkley, would replace the November 12 ban with a regulated system: 5mg THC per serving, 50mg per container, 21-and-over, mandatory testing, packaging standards. The bill has not moved out of committee.

Separately, House Agriculture Committee Chairman Glenn Thompson filed an 802-page Farm Bill draft in February 2026 that addresses industrial hemp but does not directly engage the consumable product ban. Chairman Thompson has taken the position that regulation of finished goods falls outside the Agriculture Committee's jurisdiction.

President Trump issued an executive order in December 2025 directing executive departments and agencies to develop regulations for hemp-derived THC products and expand research into them. Hemp advocates see it as promising. It does not repeal Section 781, which only Congress can do, but it does signal a policy preference for regulation over outright prohibition.

Most plausible outcome: the federal deadline takes effect on schedule. State-level litigation carves out exceptions in Texas, Ohio, and possibly other states for specific product categories or specific plaintiffs. Federal enforcement is uneven, concentrated on interstate distributors and large online retailers, and largely absent at the level of individual smoke shops and convenience stores. Payment processing, insurance, and commercial leasing withdraw support for hemp-derived products regardless of enforcement pattern, which drives the commercial shutdown faster than federal action alone would.

When does the hemp ban start affecting store shelves?

The legal deadline is November 12, 2026, but the practical contraction starts months earlier. Processors stop buying biomass in July or August because finished product cycles run 60 to 90 days. Retail selection thins by September, gets cut in half by October, and bottoms out in early November as the largest chains burn through reserves.

For the full schedule of every milestone between now and November, see our hemp ban timeline.

For hemp operators, the real sales deadline comes ahead of November 12 because processors stop buying raw biomass when they can't sell the finished product in time to liquidate. Working back from November 12 through a typical 60-90 day manufacturing and distribution cycle, the last viable purchase orders for conversion-grade CBD biomass go out in July or August 2026. Cultivators who planted in spring 2026 expecting normal buyer demand will find the buyer pool thinning dramatically by late summer.

For retailers, shelf availability of hemp-derived intoxicating products starts contracting in September as distributors prioritize their existing customer relationships and stop accepting new orders. By October, expect product selection at most independent smoke shops and vape stores to be cut roughly in half. By early November, only the largest chains with the deepest inventory reserves will still be carrying full assortments.

For consumers who want to stock up before the ban takes effect, the window is narrower than the November 12 date suggests. The effective shopping deadline is August for full product selection, October for limited selection.

For hemp operators considering cross-border inventory movements, the federal illegality kicks in at the November 12 stroke. After that date, exporting plant material that no longer qualifies as federally lawful hemp becomes unlawful, even if the crop was cultivated prior to the deadline. Customs export procedures, carrier policies, and foreign import certification requirements all close simultaneously. Inventory held on November 13 that doesn't meet the new thresholds becomes effectively immovable and subject to destruction.

State-by-state impact

The law is federal, but the consumer experience is state-specific. How hard the November 12 transition hits you depends entirely on whether you have access to a state-licensed cannabis program.

Adult-use legal states (California, Colorado, Michigan, Massachusetts, Illinois, New York, New Jersey, Nevada, Oregon, Washington, Maryland, Arizona, Missouri, Minnesota, and others): The ban is an inconvenience, not a crisis. Dispensary channels continue operating unchanged. Expect dispensary traffic to increase and prices to hold or tick up modestly as displaced hemp-derived consumers migrate in. The product quality difference matters: dispensary cannabis is lab-tested, dose-accurate, and tracked seed-to-sale. The hemp-derived products many consumers were buying online were not any of those things.

See our dispensary directories for state-specific guides: California, Michigan, Illinois, Colorado, Massachusetts, New York, New Jersey, Nevada, Oregon, Washington, Maryland, Arizona, Missouri, Minnesota.

Medical-only states (Florida, Pennsylvania, Ohio, Kentucky, North Carolina, Texas medical program, Georgia, and several others): Access narrows but doesn't disappear. If you qualify for a medical card, the program becomes your primary channel after November 12. Qualifying conditions vary by state but have generally expanded over the past three years. For consumers who were using hemp-derived products specifically because they couldn't access a dispensary, the card application is worth pursuing.

No-access states (Idaho, Wyoming, South Dakota, Nebraska, Kansas, and a handful of others): These are the hardest-hit jurisdictions. Low-dose CBD products that meet the 0.4mg cap will remain available, but anything with meaningful psychoactive effect becomes legally unavailable without traveling to a recreational state. Interstate travel to purchase personal-use quantities in a legal state is a federal offense under the Controlled Substances Act, though it's rarely prosecuted. State-level legalization pressure is likely to intensify in these jurisdictions through 2027-2028 as the commercial vacuum created by the ban pushes demand toward either state reform or gray-market supply.

Active state-level litigation states (Texas, Ohio): The short-term picture is different because court orders are currently blocking state-level rules that would have gone further than Section 781 required. The federal November 12 deadline still applies in both states regardless of how the state-level litigation resolves. Winning at the state level is a partial victory at best.

What should I do now if I buy hemp-derived edibles?

The path depends on state access. In adult-use states, transition to a dispensary before November 12 and learn the menu. In medical-only states, apply for a card now since processing takes weeks. In no-access states, low-dose CBD under 0.4mg per container stays legal but THC-bearing products become unavailable through legal channels.

Four reader types, four action paths.

If you're a hemp-derived THC consumer in a state with dispensary access, your transition is to the local dispensary starting at some point between now and November 12. The product will be more expensive per milligram, better on every quality dimension, and legal. You will need ID. If you're in a medical-only state, you'll need a card. Use the months before November to visit a dispensary, understand the product menu, identify brands that work for you, and build a supply relationship. Brands with strong state-licensed footprints that we review regularly include Kiva, Wyld, Wana, Papa & Barkley, 1906, Camino, and Smokiez.

If you're a hemp-derived consumer in a state with no dispensary access, start by researching whether your state has any medical program at all (even a limited one) and whether you qualify. Qualifying conditions have expanded significantly over the past three years in states like Texas, Georgia, Kentucky, and North Carolina. If no medical pathway exists and interstate travel isn't feasible, low-dose CBD products that meet the new 0.4mg cap remain available and legal. Products with meaningful THC content become effectively unavailable through legal channels after November 12.

If you're a CBD consumer (non-intoxicating use for sleep, pain, topical applications), most of your purchasing patterns are unaffected. Check the labels on products you currently buy against the 0.4mg per container threshold. Isolate-based products generally pass. Full-spectrum products generally fail. Switching to compliant alternatives before November 12 ensures uninterrupted access. Brands like Charlotte's Web and the isolate lines from larger operators are positioned to continue supplying the CBD-only market legally.

If you're a hemp industry operator, the action path depends on your product mix, your state, and your capital position. Reformulate intoxicating products to compliant CBD isolate formulations where possible. Pursue state cannabis licenses where your state program is accepting applications (this is a multi-year pathway, not a November fix). Liquidate non-compliant inventory on the fastest realistic timeline, recognizing that the effective sales deadline is August-September, not November. Consult counsel on bankruptcy eligibility and federal controlled-substance exposure.

What this means for the state-licensed cannabis edibles market

EdibleRank covers state-licensed cannabis edibles almost exclusively. The November 12 ban is net positive for the category we cover.

Demand migration from hemp-derived channels to dispensary channels is the primary shift. How much demand migrates depends on state access. In states with mature adult-use markets (California, Michigan, Illinois, Massachusetts), the migration is substantial and dispensary producers will ramp up capacity to meet it. In states with weaker medical programs or no access at all, migration is partial or nonexistent.

Price effects are modest and depend on supply capacity. State-licensed producers have existing manufacturing infrastructure and regulatory capacity to scale, but new edibles capacity takes months to bring online. Expect dispensary edibles prices to hold steady or tick up 5-15% through the first half of 2027 as supply catches up to new demand.

Brand consolidation accelerates. Brands that have been operating disciplined state-licensed businesses (Kiva, Wyld, Wana, Papa & Barkley, 1906, Smokiez, Mary's Medicinals, Camino, and others we review regularly) are positioned to gain share. Brands that were riding the hemp-derived channel as a growth vector are positioned to lose. Surviving the ban is one bar. Qualifying as a medical product is a higher one, and the rubric for that is laid out in what a medically endorsed edible would actually look like. For our reader taxonomy of which specific brands survive and which don't, see which cannabis brands survive the 2026 hemp ban.

Last word

The 2026 hemp ban is the largest single disruption to cannabis retail since 2018. For consumers who've been buying hemp-derived intoxicating products online or at smoke shops, it's the end of a product category. For the state-licensed cannabis industry, it's a consolidation event. We argue the same point at category scale in The Future Is Edible: the ban compresses about three years of consolidation into about six months, and the format that absorbs the displaced demand is overwhelmingly oral, not combusted. For the hemp industry itself, it's existential. The underlying policy direction (federal government increasingly inclined to treat intoxicating cannabinoids as a state-regulated category instead of a federally-unregulated one) is unlikely to reverse regardless of how Section 781 is modified or litigated.

This page gets updated whenever the situation moves. Bookmark it. Check back when news breaks. The update log at the top will tell you what's new.